{"pub": "marketwatch", "url": "https://wsj.com/articles/intraparty-disputes-dim-outlook-for-drug-price-legislation-11572255005", "downloaded_at": "2019-10-28 09:50:53.208102+00:00", "title": "Intraparty Disputes Dim Outlook for Drug-Price Legislation", "language": "en", "text": "WASHINGTON\u2014Congressional lawmakers who pledged to lower drug prices are confronting the prospect that intraparty divides and possible impeachment proceedings may prevent them from getting anything major done this year.\n\nThe White House, eager for a win as other drug-price initiatives have sputtered, is pushing Congress to compromise, but a plan in the Democratic-controlled House has become saddled with demands from progressives who say it doesn\u2019t go far enough, and a bipartisan Senate bill is also on shaky ground, with some...", "description": "Congressional lawmakers who pledged to lower drug prices are confronting the prospect that intraparty divides and possible impeachment proceedings may prevent them from getting anything major done this year.", "authors": ["Stephanie Armour", "Stephanie.Armour Wsj.Com"], "top_image": "https://images.wsj.net/im-120325/social", "published_at": "2019-10-28"}